The Contribution of Imaging as a Prognostic Marker of Luminal Breast Cancer

Radiology. 2022 Aug;304(2):320-321. doi: 10.1148/radiol.220748. Epub 2022 May 10.

Author

Masako Kataoka¹

Affiliation

¹ From the Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin-kawaharacho Sakyo-ku, Kyoto 606-8507 Japan.

PMID: 35536138
DOI: 10.1148/radiol.220748

No abstract available

Publication types

Editorial
Comment

MeSH terms

Breast Neoplasms* / diagnostic imaging
Breast Neoplasms* / mortality
Calcinosis*
Edema
Female
Humans
Neoadjuvant Therapy
Prognosis
Receptor, ErbB-2
Receptors, Progesterone

Substances

Receptors, Progesterone
Receptor, ErbB-2